FDA Inspection
Merck Sharp & Dohme LLCMerck Sharp & Dohme LLC – FDA Inspection, Feb 13, 2026
Record Details
This FDA Inspection record concerns Merck Sharp & Dohme LLC, with an inspection on February 13, 2026, issued by the Atlanta District Office, covering biologics.
View Company Profile
ID · 9216b671-d9fd-402d-b0b7-e8fc78e282e7
Inspection Facts
- Inspection number
- 1307924
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Merck Sharp & Dohme LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 12, 2025 | Not classified | Atlanta District Office | Drug Quality Assurance |
| November 16, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 5, 2019 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| May 3, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 21, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Merck Sharp & Dohme LLC
- FDA Inspection 1281516 - 2025-09-12
- FDA Inspection 1225396 - 2023-11-16
- FDA Inspection 1089774 - 2019-04-05
- FDA Inspection 1056085 - 2018-05-03
- FDA Inspection 961626 - 2016-01-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.